http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-460464-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1997-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d1c6fae55cb5b3136930ad6849396db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6836d749bd9210ad42c35713390255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1fbd95434a80255d105dd7e076e61b1 |
| publicationDate | 2001-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-460464-B |
| titleOfInvention | Novel phenanthridinium derivative having an anti-tumor activity and pharmaceutical composition containing the same |
| abstract | Wherein R1 represents a substituted or unsubstituted lower aliphatic hydrocarbon; R represents an aliphatic hydrocarbon chain having 2 to 6 carbon atoms which may have a substituent(s) selected from the group consisting of a lower alkyl group, a halogen group and a hydroxyl group; Y and Z independently represent a hydrogen atom, a hydroxyl group or a lower alkoxyl group, or Y and Z may, together therewith, form a methylenedioxyl group or a phenyl ring; X<SP>-</SP> represents an acid residue or a hydroacid residue, has an anti-tumor activity and a resistance to a chemical reductive reaction and a biological metabolism reaction, and is therefore advantageous as a drug. |
| priorityDate | 1996-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 181.